A detailed history of Td Waterhouse Canada Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 1,360 shares of EXAS stock, worth $95,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,360
Previous 1,137 19.61%
Holding current value
$95,961
Previous $83.8 Million 54.19%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$41.33 - $74.26 $9,216 - $16,559
223 Added 19.61%
1,360 $129 Million
Q1 2024

May 10, 2024

BUY
$56.27 - $73.77 $21,776 - $28,548
387 Added 51.6%
1,137 $83.8 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $13,188 - $19,808
200 Added 36.36%
750 $49.8 Million
Q2 2023

Nov 13, 2023

BUY
$62.68 - $95.05 $34,474 - $52,277
550 New
550 $51.6 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.